Toll Free: 1-888-928-9744
Published: Feb, 2018 | Pages:
117 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the Asia-Pacific Spinal Muscular Atrophy Medicine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Spinal Muscular Atrophy Medicine for these regions, from 2013 to 2025 (forecast), including China Japan South Korea Taiwan India Southeast Asia Australia Asia-Pacific Spinal Muscular Atrophy Medicine market competition by top manufacturers/players, with Spinal Muscular Atrophy Medicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Astellas Pharma Inc. AveXis, Inc. Bioblast Pharma Ltd. Cytokinetics, Inc. 24 F. Hoffmann-La Roche Ltd. Genethon Genzyme Corporation GMP-Orphan SAS Ionis Pharmaceuticals, Inc. Longevity Biotech, Inc Neurodyn Inc. Neurotune AG Novartis AG Sarepta Therapeutics, Inc. Voyager Therapeutics, Inc. Vybion, Inc. WAVE Life Sciences Ltd. On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into LMI-070 ND-602 NT-1654 Nusinersen NXD-30001 Others On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Hospital Clinic Others If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents Asia-Pacific Spinal Muscular Atrophy Medicine Market Report 2018 1 Spinal Muscular Atrophy Medicine Overview 1.1 Product Overview and Scope of Spinal Muscular Atrophy Medicine 1.2 Classification of Spinal Muscular Atrophy Medicine by Product Category 1.2.1 Asia-Pacific Spinal Muscular Atrophy Medicine Market Size (Sales) Comparison by Types (2013-2025) 1.2.2 Asia-Pacific Spinal Muscular Atrophy Medicine Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 LMI-070 1.2.4 ND-602 1.2.5 NT-1654 1.2.6 Nusinersen 1.2.7 NXD-30001 1.2.8 Others 1.3 Asia-Pacific Spinal Muscular Atrophy Medicine Market by Application/End Users 1.3.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales (Volume) and Market Share Comparison by Applications (2013-2025) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Asia-Pacific Spinal Muscular Atrophy Medicine Market by Region 1.4.1 Asia-Pacific Spinal Muscular Atrophy Medicine Market Size (Value) Comparison by Region (2013-2025) 1.4.2 China Status and Prospect (2013-2025) 1.4.3 Japan Status and Prospect (2013-2025) 1.4.4 South Korea Status and Prospect (2013-2025) 1.4.5 Taiwan Status and Prospect (2013-2025) 1.4.6 India Status and Prospect (2013-2025) 1.4.7 Southeast Asia Status and Prospect (2013-2025) 1.4.8 Australia Status and Prospect (2013-2025) 1.5 Asia-Pacific Market Size (Value and Volume) of Spinal Muscular Atrophy Medicine (2013-2025) 1.5.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales and Growth Rate (2013-2025) 1.5.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2025) 2 Asia-Pacific Spinal Muscular Atrophy Medicine Competition by Players/Suppliers, Region, Type and Application 2.1 Asia-Pacific Spinal Muscular Atrophy Medicine Market Competition by Players/Suppliers 2.1.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume and Market Share of Key Players/Suppliers (2013-2018) 2.1.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Share by Players/Suppliers (2013-2018) 2.2 Asia-Pacific Spinal Muscular Atrophy Medicine (Volume and Value) by Type 2.2.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales and Market Share by Type (2013-2018) 2.2.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Market Share by Type (2013-2018) 2.3 Asia-Pacific Spinal Muscular Atrophy Medicine (Volume) by Application 2.4 Asia-Pacific Spinal Muscular Atrophy Medicine (Volume and Value) by Region 2.4.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales and Market Share by Region (2013-2018) 2.4.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Market Share by Region (2013-2018) 3 China Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price) 3.1 China Spinal Muscular Atrophy Medicine Sales and Value (2013-2018) 3.1.1 China Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018) 3.1.2 China Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018) 3.1.3 China Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018) 3.2 China Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type 3.3 China Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application 4 Japan Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price) 4.1 Japan Spinal Muscular Atrophy Medicine Sales and Value (2013-2018) 4.1.1 Japan Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018) 4.1.2 Japan Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018) 4.1.3 Japan Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018) 4.2 Japan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type 4.3 Japan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application 5 South Korea Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price) 5.1 South Korea Spinal Muscular Atrophy Medicine Sales and Value (2013-2018) 5.1.1 South Korea Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018) 5.1.2 South Korea Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018) 5.1.3 South Korea Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018) 5.2 South Korea Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type 5.3 South Korea Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application 6 Taiwan Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price) 6.1 Taiwan Spinal Muscular Atrophy Medicine Sales and Value (2013-2018) 6.1.1 Taiwan Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018) 6.1.2 Taiwan Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018) 6.1.3 Taiwan Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018) 6.2 Taiwan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type 6.3 Taiwan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application 7 India Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price) 7.1 India Spinal Muscular Atrophy Medicine Sales and Value (2013-2018) 7.1.1 India Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018) 7.1.2 India Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018) 7.1.3 India Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018) 7.2 India Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type 7.3 India Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application 8 Southeast Asia Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price) 8.1 Southeast Asia Spinal Muscular Atrophy Medicine Sales and Value (2013-2018) 8.1.1 Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018) 8.1.2 Southeast Asia Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018) 8.1.3 Southeast Asia Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018) 8.2 Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type 8.3 Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application 9 Australia Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price) 9.1 Australia Spinal Muscular Atrophy Medicine Sales and Value (2013-2018) 9.1.1 Australia Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018) 9.1.2 Australia Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018) 9.1.3 Australia Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018) 9.2 Australia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type 9.3 Australia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application 10 Asia-Pacific Spinal Muscular Atrophy Medicine Players/Suppliers Profiles and Sales Data 10.1 Astellas Pharma Inc. 10.1.1 Company Basic Information, Manufacturing Base and Competitors 10.1.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 10.1.2.1 Product A 10.1.2.2 Product B 10.1.3 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018) 10.1.4 Main Business/Business Overview 10.2 AveXis, Inc. 10.2.1 Company Basic Information, Manufacturing Base and Competitors 10.2.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 10.2.2.1 Product A 10.2.2.2 Product B 10.2.3 AveXis, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018) 10.2.4 Main Business/Business Overview 10.3 Bioblast Pharma Ltd. 10.3.1 Company Basic Information, Manufacturing Base and Competitors 10.3.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 10.3.2.1 Product A 10.3.2.2 Product B 10.3.3 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018) 10.3.4 Main Business/Business Overview 10.4 Cytokinetics, Inc. 24 10.4.1 Company Basic Information, Manufacturing Base and Competitors 10.4.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 10.4.2.1 Product A 10.4.2.2 Product B 10.4.3 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018) 10.4.4 Main Business/Business Overview 10.5 F. Hoffmann-La Roche Ltd. 10.5.1 Company Basic Information, Manufacturing Base and Competitors 10.5.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 10.5.2.1 Product A 10.5.2.2 Product B 10.5.3 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018) 10.5.4 Main Business/Business Overview 10.6 Genethon 10.6.1 Company Basic Information, Manufacturing Base and Competitors 10.6.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 10.6.2.1 Product A 10.6.2.2 Product B 10.6.3 Genethon Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018) 10.6.4 Main Business/Business Overview 10.7 Genzyme Corporation 10.7.1 Company Basic Information, Manufacturing Base and Competitors 10.7.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 10.7.2.1 Product A 10.7.2.2 Product B 10.7.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018) 10.7.4 Main Business/Business Overview 10.8 GMP-Orphan SAS 10.8.1 Company Basic Information, Manufacturing Base and Competitors 10.8.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 10.8.2.1 Product A 10.8.2.2 Product B 10.8.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018) 10.8.4 Main Business/Business Overview 10.9 Ionis Pharmaceuticals, Inc. 10.9.1 Company Basic Information, Manufacturing Base and Competitors 10.9.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 10.9.2.1 Product A 10.9.2.2 Product B 10.9.3 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018) 10.9.4 Main Business/Business Overview 10.10 Longevity Biotech, Inc 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification 10.10.2.1 Product A 10.10.2.2 Product B 10.10.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018) 10.10.4 Main Business/Business Overview 10.11 Neurodyn Inc. 10.12 Neurotune AG 10.13 Novartis AG 10.14 Sarepta Therapeutics, Inc. 10.15 Voyager Therapeutics, Inc. 10.16 Vybion, Inc. 10.17 WAVE Life Sciences Ltd. 11 Spinal Muscular Atrophy Medicine Manufacturing Cost Analysis 11.1 Spinal Muscular Atrophy Medicine Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.1.2 Price Trend of Key Raw Materials 11.1.3 Key Suppliers of Raw Materials 11.1.4 Market Concentration Rate of Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine 12 Industrial Chain, Sourcing Strategy and Downstream Buyers 12.1 Spinal Muscular Atrophy Medicine Industrial Chain Analysis 12.2 Upstream Raw Materials Sourcing 12.3 Raw Materials Sources of Spinal Muscular Atrophy Medicine Major Manufacturers in 2017 12.4 Downstream Buyers 13 Marketing Strategy Analysis, Distributors/Traders 13.1 Marketing Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Development Trend 13.2 Market Positioning 13.2.1 Pricing Strategy 13.2.2 Brand Strategy 13.2.3 Target Client 13.3 Distributors/Traders List 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes Threat 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs/Customer Preference Change 14.3 Economic/Political Environmental Change 15 Asia-Pacific Spinal Muscular Atrophy Medicine Market Forecast (2018-2025) 15.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Price Forecast (2018-2025) 15.1.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate Forecast (2018-2025) 15.1.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Growth Rate Forecast (2018-2025) 15.1.3 Asia-Pacific Spinal Muscular Atrophy Medicine Price and Trend Forecast (2018-2025) 15.2 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025) 15.2.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate Forecast by Region (2018-2025) 15.2.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Growth Rate Forecast by Region (2018-2025) 15.2.3 China Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.4 Japan Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.5 South Korea Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.6 Taiwan Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.7 India Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.8 Southeast Asia Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025) 15.2.9 Australia Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025) 15.3 Asia-Pacific Spinal Muscular Atrophy Medicine Sales, Revenue and Price Forecast by Type (2018-2025) 15.3.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Forecast by Type (2018-2025) 15.3.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Forecast by Type (2018-2025) 15.3.3 Asia-Pacific Spinal Muscular Atrophy Medicine Price Forecast by Type (2018-2025) 15.4 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Forecast by Application (2018-2025) 16 Research Findings and Conclusion 17 Appendix 17.1 Methodology/Research Approach 17.1.1 Research Programs/Design 17.1.2 Market Size Estimation 17.1.3 Market Breakdown and Data Triangulation 17.2 Data Source 17.2.1 Secondary Sources 17.2.2 Primary Sources 17.3 Disclaimer
List of Tables and Figures Figure Product Picture of Spinal Muscular Atrophy Medicine Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (Product Category) in 2017 Figure LMI-070 Product Picture Figure ND-602 Product Picture Figure NT-1654 Product Picture Figure Nusinersen Product Picture Figure NXD-30001 Product Picture Figure Others Product Picture Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales (K Pcs) by Application (2013-2025) Figure Asia-Pacific Sales Market Share of Spinal Muscular Atrophy Medicine by Application in 2017 Figure Hospital Examples Table Key Downstream Customer in Hospital Figure Clinic Examples Table Key Downstream Customer in Clinic Figure Others Examples Table Key Downstream Customer in Others Figure Asia-Pacific Spinal Muscular Atrophy Medicine Market Size (Million USD) by Region (2013-2025) Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure South Korea Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure Taiwan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure Australia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate (2013-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Market Major Players Product Sales Volume (K Pcs)(2013-2018) Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales (K Pcs) of Key Players/Suppliers (2013-2018) Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Players/Suppliers (2013-2018) Figure 2017 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Players/Suppliers Figure 2017 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Players/Suppliers Figure Asia-Pacific Spinal Muscular Atrophy Medicine Market Major Players Product Revenue (Million USD) 2013-2018 Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) by Players/Suppliers (2013-2018) Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share by Players/Suppliers (2013-2018) Figure 2017 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share by Players Figure 2017 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share by Players Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales and Market Share by Type (2013-2018) Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Type (2013-2018) Figure Sales Market Share of Spinal Muscular Atrophy Medicine by Type (2013-2018) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Growth Rate by Type (2013-2018) Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) and Market Share by Type (2013-2018) Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share by Type (2013-2018) Figure Revenue Market Share of Spinal Muscular Atrophy Medicine by Type (2013-2018) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Growth Rate by Type (2013-2018) Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Market Share by Region (2013-2018) Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Region (2013-2018) Figure Sales Market Share of Spinal Muscular Atrophy Medicine by Region (2013-2018) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share by Region in 2017 Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) and Market Share by Region (2013-2018) Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share (%) by Region (2013-2018) Figure Revenue Market Share of Spinal Muscular Atrophy Medicine by Region (2013-2018) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Market Share by Region in 2017 Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Market Share by Application (2013-2018) Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share (%) by Application (2013-2018) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share by Application (2013-2018) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share by Application (2013-2018) Figure China Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018) Figure China Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018) Table China Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018) Table China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018) Figure China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017 Table China Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018) Table China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018) Figure China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017 Figure Japan Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018) Figure Japan Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018) Table Japan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018) Table Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018) Figure Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017 Table Japan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018) Table Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018) Figure Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017 Figure South Korea Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure South Korea Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018) Figure South Korea Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018) Table South Korea Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018) Table South Korea Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018) Figure South Korea Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017 Table South Korea Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018) Table South Korea Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018) Figure South Korea Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017 Figure Taiwan Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure Taiwan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018) Figure Taiwan Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018) Table Taiwan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018) Table Taiwan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018) Figure Taiwan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017 Table Taiwan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018) Table Taiwan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018) Figure Taiwan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017 Figure India Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018) Figure India Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018) Table India Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018) Table India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018) Figure India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017 Table India Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Application (2013-2018) Table India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018) Figure India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017 Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018) Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018) Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018) Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018) Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017 Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018) Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018) Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017 Figure Australia Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure Australia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018) Figure Australia Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018) Table Australia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018) Table Australia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018) Figure Australia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017 Table Australia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018) Table Australia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018) Figure Australia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017 Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Basic Information List Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018) Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018) Table AveXis, Inc. Spinal Muscular Atrophy Medicine Basic Information List Table AveXis, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018) Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018) Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Basic Information List Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018) Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018) Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Basic Information List Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018) Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018) Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Basic Information List Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018) Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018) Table Genethon Spinal Muscular Atrophy Medicine Basic Information List Table Genethon Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Genethon Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure Genethon Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018) Figure Genethon Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018) Table Genzyme Corporation Spinal Muscular Atrophy Medicine Basic Information List Table Genzyme Corporation Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018) Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018) Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Basic Information List Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018) Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018) Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Basic Information List Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018) Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018) Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Basic Information List Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018) Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018) Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018) Table Neurodyn Inc. Spinal Muscular Atrophy Medicine Basic Information List Table Neurotune AG Spinal Muscular Atrophy Medicine Basic Information List Table Novartis AG Spinal Muscular Atrophy Medicine Basic Information List Table Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Basic Information List Table Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Basic Information List Table Vybion, Inc. Spinal Muscular Atrophy Medicine Basic Information List Table WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price (USD/Pcs) Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Spinal Muscular Atrophy Medicine Figure Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine Figure Spinal Muscular Atrophy Medicine Industrial Chain Analysis Table Raw Materials Sources of Spinal Muscular Atrophy Medicine Major Manufacturers in 2017 Table Major Buyers of Spinal Muscular Atrophy Medicine Table Distributors/Traders List Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Price (USD/Pcs) and Trend Forecast (2018-2025) Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) Forecast by Region (2018-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume Market Share Forecast by Region (2018-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume Market Share Forecast by Region in 2025 Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) Forecast by Region (2018-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Region (2018-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Region in 2025 Figure China Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Japan Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure South Korea Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure South Korea Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Taiwan Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure Taiwan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure India Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Australia Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure Australia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025) Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales (K Pcs) Forecast by Type (2018-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share Forecast by Type (2018-2025) Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) Forecast by Type (2018-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Type (2018-2025) Table Asia-Pacific Spinal Muscular Atrophy Medicine Price (USD/Pcs) Forecast by Type (2018-2025) Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales (K Pcs) Forecast by Application (2018-2025) Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share Forecast by Application (2018-2025) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.